Tiba wins BARDA contract to develop RNA bird flu vaccine – Fierce Biotech The $749999 contract will see Tiba Biotech build on previous work to develop new a RNA-based vaccine against the H1N1 strain of the bird flu. Read More at Source. Share this: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook More Share on LinkedIn (Opens in new window) LinkedIn Share on Reddit (Opens in new window) Reddit Share on Tumblr (Opens in new window) Tumblr Share on Pinterest (Opens in new window) Pinterest Share on Telegram (Opens in new window) Telegram Share on WhatsApp (Opens in new window) WhatsApp Like this:Like Loading… Related Tags: BirdNews July 11, 2024 by Pumilo Bird News 0
